$MBI SEC Filings

Filed On	Filing
14 Aug 2026	SCHEDULE 13G
13 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Jul 2026	SCHEDULE 13G
09 Jun 2026	11-K
14 May 2026	SCHEDULE 13G/A
13 May 2026	Form 4: Innis-Thompson Janice L., Director Received 16,181 shares as a grant or award ($100K)
13 May 2026	Form 4: Gilbert Steven J, Director Received 16,181 shares as a grant or award ($100K)
13 May 2026	Form 4: Dewbrey Diane L, Director Received 16,181 shares as a grant or award ($100K)
13 May 2026	Form 4: Vaughan Richard C, Director Received 16,181 shares as a grant or award ($100K)
13 May 2026	Form 4: Shasta Theodore, Director Received 16,181 shares as a grant or award ($100K)
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Apr 2026	DEFA14A
27 Mar 2026	SCHEDULE 13G/A
23 Mar 2026	ARS
23 Mar 2026	Proxy statement: annual meeting on May 5, 2026 CEO pay $4.3M, up 9.8% · say-on-pay vote
05 Mar 2026	Form 4: Fallon William C, Director Gave up 39,658 shares to cover exercise price or tax ($273K)
05 Mar 2026	Form 4: Bergonzi Adam T., Assistant Vice President Gave up 13,280 shares to cover exercise price or tax ($91.4K)

Comments